Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

448 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH

NCT04463056

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +20 more
Locations
  • Federal State Budget Funded Institution National Medical Research Center of Hematology, Ministry of Health of the Russian Federation (MoH of Russia) Moscow, Russia
  • Moscow State Budget Funded Healthcare Institution S. P. Botkin City Clinical Hospital, Moscow Department of Healthcare Moscow, Russia
  • State Budget Funded Institution of Higher Education Academician I. P. Pavlov Saint-Petersburg State Medical University of the Ministry of Health of the Russian Federation Saint Petersburg, Russia
  • State Budgetary Educational Institution of Higher Professional Education Samara State Medical University, Ministry of Health of the Russian Federation. Samara, Russia
View Trial Details
Completed

ALLO-SCT in Elderly Patients With Hematological Disease

NCT04386928

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Stem Cell Transplant Complications
Locations
  • Azienda Ospedaliero-Universitaria Ospedali Riuniti Ancona, Italy
  • Ospedale Mazzoni Ascoli Piceno, Italy
  • Policlinico di Bari-Ematologia con trapianti Bari, Italy
  • Ospedale San Orsola Bologna, Italy
View all 29 locations
View Trial Details
Completed

High Resolution Donor Recipient HLA Matching Level in Unrelated HSCT

NCT02827149

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases
Locations
  • Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy
  • Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy
  • Ospedale Mazzoni Ascoli Piceno, Italy
  • Policlinico di Bari-Ematologia con trapianti Bari, Italy
View all 39 locations
View Trial Details
Completed

Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.

NCT02038036

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Novartis Investigative Site Herston, Queensland, Australia
  • Novartis Investigative Site Antwerp, Belgium
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 48 locations
View Trial Details
Completed

Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers

NCT00223483

Conditions
Healthy Volunteers, Hematologic Diseases, Hemic and Lymphatic Diseases
Locations
  • Department of Veterans Affairs, South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division San Antonio, Texas, United States
  • The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
View Trial Details

Related conditions